"Late on Friday, Bloomberg reported that Hims & Hers has reached an agreement with the Danish drugmaker Novo Nordisk to sell Novo's weight-loss drugs, including the popular GLP-1 pill Wegovy. According to the publication, which cited an anonymous source, the news could be publicly announced as soon as today."
"The reported partnership between the two firms would be a stunning reversal in their relationship, which, as recently as last month, was highly acrimonious. Their feud stems from an announcement in early February that Hims & Hers would sell a compounded version of Novo's Wegovy weight-loss pill at a third of the price Novo sells it for."
Hims & Hers Health's stock price soared following an unconfirmed Bloomberg report that the telehealth company reached an agreement with Danish pharmaceutical company Novo Nordisk to sell Novo's weight-loss drugs, including the popular GLP-1 medication Wegovy. The reported partnership marks a dramatic reversal in the companies' relationship, which deteriorated last month when Novo threatened legal action against Hims & Hers. The conflict originated when Hims & Hers announced plans to sell a compounded version of Wegovy at approximately one-third of Novo's price. The potential deal announcement could occur imminently, though both companies have not yet publicly confirmed the agreement.
Read at Fast Company
Unable to calculate read time
Collection
[
|
...
]